Apremilast in Refractory Behçet’s Syndrome: A Multicenter Observational Study

OBJECTIVE: Mucocutaneous and joint disorders are the most common manifestations in Behçet’s syndrome (BS) and are frequently clustered in the so-called minor forms of BS. There remains a need for safe and effective treatment for joint lesions in BS. We report the long-term safety and effectiveness o...

Descripción completa

Detalles Bibliográficos
Autores principales: Vieira, Matheus, Buffier, Solène, Vautier, Mathieu, Le Joncour, Alexandre, Jamilloux, Yvan, Gerfaud-Valentin, Mathieu, Bouillet, Laurence, Lazaro, Estibaliz, Barete, Stéphane, Misery, Laurent, Gobert, Delphine, Goulenok, Tiphaine, Fain, Olivier, Sacre, Karim, Sève, Pascal, Cacoub, Patrice, Comarmond, Cloé, Saadoun, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889954/
https://www.ncbi.nlm.nih.gov/pubmed/33613571
http://dx.doi.org/10.3389/fimmu.2020.626792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889954/
https://www.ncbi.nlm.nih.gov/pubmed/33613571
http://dx.doi.org/10.3389/fimmu.2020.626792

Ejemplares similares